{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:19:03Z","timestamp":1787167143852,"version":"build-2736575974"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0238027","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T13:33:55Z","timestamp":1598362435000},"page":"e0238027","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1441-2308","authenticated-orcid":true,"given":"Ann Abiola","family":"Ogbenna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Meloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Inzaule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raph L.","family":"Hamers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Sigaloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akin","family":"Osibogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titilope Adenike","family":"Adeyemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prosper","family":"Okonkwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay Osi","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis J.","family":"Kanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias F.","family":"Rinke de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alani Sulaimon","family":"Akanmu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"pone.0238027.ref001","unstructured":"Unaids. Fact sheet\u2014Latest global and regional statistics on the status of the AIDS epidemic. [Internet]. [cited 2018 Mar 12]. Available from: http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf"},{"key":"pone.0238027.ref002","unstructured":"UNAIDS. Nigeria | UNAIDS [Internet]. UNAIDS. 2018 [cited 2018 Mar 12]. Available from: http:\/\/www.unaids.org\/en\/regionscountries\/countries\/nigeria"},{"issue":"8","key":"pone.0238027.ref003","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm.2016","article-title":"A new human immunodeficiency virus derived from gorillas","volume":"15","author":"J Plantier","year":"2009","journal-title":"Nat Med"},{"issue":"2","key":"pone.0238027.ref004","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1155\/2013\/230380","article-title":"Increasing HIV subtype diversity and its clinical implications in a sentinel North American population","volume":"24","author":"RA Siemieniuk","year":"2013","journal-title":"Can J Infect Dis Med Microbiol = J Can des Mal Infect la Microbiol medicale"},{"key":"pone.0238027.ref005","volume-title":"Antiretroviral Resistance in Clinical Practice","author":"R Camacho","year":"2006"},{"issue":"255","key":"pone.0238027.ref006","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/QAD.0b013e328342ff93","article-title":"Global trends in molecular epidemiology of HIV-1 during 2000\u20132007 and WHO-UNAIDS Network for HIV Isolation and Characterisation","volume":"13","author":"J Hemelaar","year":"2011","journal-title":"AIDS March"},{"issue":"8","key":"pone.0238027.ref007","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1089\/aid.2006.0304","article-title":"The Complexity of Circulating HIV Type 1 Strains in Oyo State, Nigeria","volume":"23","author":"J-L Sankal\u00e9","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0238027.ref008","author":"B Chaplin","year":"2011","journal-title":"Impact of HIV Type 1 Subtype on Drug Resistance Mutations in Nigerian Patients Failing First-Line Therapy"},{"issue":"12","key":"pone.0238027.ref009","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1089\/aid.2007.0064","article-title":"Characterization of HIV Type 1 Reverse Transcriptase Mutations in Infants Infected by Mothers Who Received Peripartum Nevirapine Prophylaxis in Jos, Nigeria","volume":"23","author":"AI Ojesina","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"16","key":"pone.0238027.ref010","first-page":"2131","article-title":"Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials","volume":"20","author":"SM Agwale","year":"2002","journal-title":"Vaccine"},{"issue":"4","key":"pone.0238027.ref011","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/088922200309197","article-title":"Predominance of Subtype A and G HIV Type 1 in Nigeria, with Geographical Differences in Their Distribution","volume":"16","author":"M Peeters","year":"2000","journal-title":"AIDS Res Hum RETROVIRUSES"},{"issue":"2","key":"pone.0238027.ref012","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1155\/2013\/230380","article-title":"Increasing HIV subtype diversity and its clinical implications in a sentinel North American population","volume":"24","author":"RA Siemieniuk","year":"2013","journal-title":"Can J Infect Dis Med Microbiol = J Can des Mal Infect la Microbiol medicale"},{"issue":"1","key":"pone.0238027.ref013","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1086\/314557","article-title":"Human Immunodeficiency Virus Type 1 Subtypes Differ in Disease Progression","volume":"179","author":"PJ Kanki","year":"1999","journal-title":"J Infect Dis"},{"issue":"3","key":"pone.0238027.ref014","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00002030-200102160-00001","article-title":"Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort","volume":"15","author":"P Kaleebu","year":"2001","journal-title":"AIDS"},{"issue":"11","key":"pone.0238027.ref015","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/00002030-200307250-00011","article-title":"Genetic diversity of HIV-1 in western Kenya: subtype-specific differences in mother-to-child transmission","volume":"17","author":"C Yang","year":"2003","journal-title":"AIDS"},{"issue":"2","key":"pone.0238027.ref016","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/431197","article-title":"HIV\u20101 Proteases from Drug\u2010Naive West African Patients Are Differentially Less Susceptible to Protease Inhibitors","volume":"41","author":"M Kinomoto","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"8","key":"pone.0238027.ref017","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/00002030-200205240-00007","article-title":"Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy","volume":"16","author":"AJ Frater","year":"2002","journal-title":"AIDS"},{"issue":"17","key":"pone.0238027.ref018","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1097\/00002030-200411190-00016","article-title":"Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patients","volume":"18","author":"S De Wit","year":"2004","journal-title":"AIDS"},{"issue":"5","key":"pone.0238027.ref019","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1086\/342680","article-title":"Impact of Human Immunodeficiency Virus Type 1 Subtypes on Virologic Response and Emergence of Drug Resistance among Children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial","volume":"186","author":"D Pillay","year":"2002","journal-title":"J Infect Dis"},{"issue":"3","key":"pone.0238027.ref020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00126334-200307010-00007","article-title":"Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (subtype E) infection differ from subtype B infection","volume":"33","author":"K Ariyoshi","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"pone.0238027.ref021","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/cid\/cir669","article-title":"Improved Virological Outcome in White Patients Infected With HIV-1 Non-B Subtypes Compared to Subtype B","volume":"53","author":"AU Scherrer","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pone.0238027.ref022","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.17.1.18944","article-title":"Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review","volume":"17","author":"M Bhargava","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"9","key":"pone.0238027.ref023","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1086\/340130","article-title":"Effect of Human Immunodeficiency Virus (HIV) Type 1 Envelope Subtypes A and D on Disease Progression in a Large Cohort of HIV-1-Positive Persons in Uganda on JSTOR","volume":"185","author":"P Kaleebu","year":"2002","journal-title":"J Infect Dis"},{"issue":"8","key":"pone.0238027.ref024","doi-asserted-by":"crossref","first-page":"e71768","DOI":"10.1371\/journal.pone.0071768","article-title":"Effect of HIV-1 Subtypes on Disease Progression in Rural Uganda: A Prospective Clinical Cohort Study","volume":"8","author":"D Ssemwanga","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"pone.0238027.ref025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAD.0b013e328326f77f","article-title":"Impact of HIV-1 viral subtype on CD4+ T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare","volume":"23","author":"M Keller","year":"2009","journal-title":"AIDS"},{"issue":"4","key":"pone.0238027.ref026","doi-asserted-by":"crossref","first-page":"E318","DOI":"10.9778\/cmajo.20140017","article-title":"The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort study","volume":"2","author":"MB Klein","year":"2014","journal-title":"C open"},{"key":"pone.0238027.ref027","unstructured":"Federal Ministry of Health N. Guideline for the of antiretroviral (ARV) drugs in Nigeria. Federal ministry of health, Nigeria; 2007."},{"issue":"1","key":"pone.0238027.ref028","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijmedinf.2014.09.006","article-title":"Scale-up of networked HIV treatment in Nigeria: Creation of an integrated electronic medical records system","volume":"84","author":"B Chaplin","year":"2015","journal-title":"Int J Med Inform"},{"issue":"1","key":"pone.0238027.ref029","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ije\/dyq192","article-title":"Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance\u2014HIV drug resistance in sub-Saharan Africa and the Asia-Pacific","volume":"41","author":"RL Hamers","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"10","key":"pone.0238027.ref030","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S1473-3099(11)70149-9","article-title":"HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study","volume":"11","author":"RL Hamers","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"pone.0238027.ref031","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jviromet.2009.11.011","article-title":"Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1","volume":"163","author":"CL Wallis","year":"2010","journal-title":"J Virol Methods"},{"issue":"19","key":"pone.0238027.ref032","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/bioinformatics\/bti607","article-title":"An automated genotyping system for analysis of HIV-1 and other microbial sequences","volume":"21","author":"T de Oliveira","year":"2005","journal-title":"Bioinformatics"},{"issue":"5","key":"pone.0238027.ref033","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/088922204323087697","article-title":"Development of a Novel Human Immunodeficiency Virus Type 1 Subtyping Tool, Subtype Analyzer (STAR): Analysis of Subtype Distribution in London","volume":"20","author":"C V Gale","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"12","key":"pone.0238027.ref034","doi-asserted-by":"crossref","first-page":"e0166711","DOI":"10.1371\/journal.pone.0166711","article-title":"An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria","volume":"11","author":"OS Njoku","year":"2016","journal-title":"PLoS One"},{"key":"pone.0238027.ref035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-4690-3-40","article-title":"The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness","volume":"3","author":"HF Njai","year":"2006","journal-title":"Retrovirology"},{"key":"pone.0238027.ref036","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/157016207779316297","article-title":"HIV Genetic Diversity: Biological and Public Health Consequences","volume":"5","author":"IF Butler","year":"2007","journal-title":"Curr HIV Res"},{"issue":"8","key":"pone.0238027.ref037","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1089\/aid.2006.22.770","article-title":"Subtype-Specific Patterns in HIV Type 1 Reverse Transcriptase and Protease in Oyo State, Nigeria: Implications for Drug Resistance and Host Response","volume":"22","author":"AI Ojesina","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"pone.0238027.ref038","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1089\/aid.2014.0168","article-title":"Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria","volume":"31","author":"K Diallo","year":"2015","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"9","key":"pone.0238027.ref039","doi-asserted-by":"crossref","first-page":"e0137281","DOI":"10.1371\/journal.pone.0137281","article-title":"Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients","volume":"10","author":"WZ Chow","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"pone.0238027.ref040","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/aid.2006.0288","article-title":"Impact of Ethnicity and HIV Type 1 Subtype on Response to First-Line Antiretroviral Therapy","volume":"23","author":"ER De Arellano","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"9","key":"pone.0238027.ref041","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1086\/598502","article-title":"Effect of HIV\u20101 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy","volume":"48","author":"AM Geretti","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pone.0238027.ref042","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41598-017-01858-2","article-title":"HIV-1 CRF01_AE strain is associated with faster HIV\/AIDS progression in Jiangsu Province, China","volume":"7","author":"M Chu","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"pone.0238027.ref043","doi-asserted-by":"crossref","first-page":"e71174","DOI":"10.1371\/journal.pone.0071174","article-title":"Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration","volume":"8","author":"G Touloumi","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"pone.0238027.ref044","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/cid\/cis999","article-title":"Increasing HIV-1 Non-B Subtype Primary Infections in Patients in France and Effect of HIV Subtypes on Virological and Immunological Responses to Combined Antiretroviral Therapy","volume":"56","author":"M-L Chaix","year":"2013","journal-title":"Clin Infect Dis"},{"key":"pone.0238027.ref045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1758-2652-13-4","article-title":"Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy","volume":"13","author":"PJ Easterbrook","year":"2010","journal-title":"J Int AIDS Soc"},{"key":"pone.0238027.ref046","unstructured":"Bocket L, Cheret A, Deuffic-Burban S, Choisy P, Gerard Y, De La Tribonni\u00e8re X, et al. Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness. [cited 2018 Mar 12]; Available from: https:\/\/www.intmedpress.com\/serveFile.cfm?sUID=efea4375-d595-4436-80e9-fd611e7efacf"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T13:34:29Z","timestamp":1598362469000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238027"}},"subtitle":[],"editor":[{"given":"Jason","family":"Blackard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0238027","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]}}}